Recent Updates
Recently added Catalysts
VIR Positive Sentiment Score: 70/100

Vir Biotechnology to Participate in the Barclays Global Healthcare Conference

Wednesday, March 8, 2023 1 min read
Key Takeaway: Vir Biotechnology, Inc. is set to participate in the Barclays Global Healthcare Conference, where Dr. Phil Pang will present on March 15. The presentation is accessible via a live webcast on the company's website and will remain archived for 30 days. Vir Biotechnology is engaged in developing treatments for various infectious diseases through advanced immunology technology platforms.

Market Sentiment Analysis

POSITIVE FACTORS

  • Vir Biotechnology will be presenting at a prominent healthcare conference.
  • The company is focused on innovative immunology solutions for infectious diseases.
  • There is ongoing investor engagement through live webcasts.

Full Press Release Details

SAN FRANCISCO, March 08, 2023 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Phil Pang, M.D., Ph.D., Executive Vice President, Chief Medical Officer and Interim Head of Research, is scheduled to present at the Barclays Global Healthcare Conference on Wednesday, March 15, at 7:15 a.m. PT / 10:15 a.m. ET.
A live webcast of the presentation can be accessed under Events & Presentations in the Investors section of the Vir website at www.vir.bio and will be archived there for 30 days.
About Vir Biotechnology
Vir Biotechnology is a commercial-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. Vir has assembled four technology platforms that are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. Its current development pipeline consists of product candidates targeting COVID-19, hepatitis B and D viruses, influenza A and human immunodeficiency virus. Vir routinely posts information that may be important to investors on its website.

Tags

Barclays Global Healthcare

Frequently Asked Questions

When is Phil Pang scheduled to present at Barclays Conference?

Phil Pang is set to present on March 15 at 7:15 a.m. PT / 10:15 a.m. ET.

Where can I watch the live presentation of Vir Biotechnology?

The presentation can be viewed on the Vir website under Events & Presentations.

What does Vir Biotechnology focus on?

Vir Biotechnology focuses on immunology to treat and prevent serious infectious diseases.

Which viruses is Vir's development pipeline targeting?

Vir’s pipeline targets COVID-19, hepatitis B and D, influenza A, and HIV.

How long will the webcast be available after the presentation?

The webcast will be archived on the website for 30 days.

Tags: VIR Viatris Investor Conferences Healthcare Vir Biotechnology Barclays Global Healthcare Conference immunology infectious diseases
Last updated: Mar 8, 2023